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Abstract
Background: Although Dengue virus (DENV) circulation had been documented in neighbouring South-western Indian
Ocean Islands, its presence in Mayotte is poorly characterised. To address this issue, we aimed to assess the seroprevalence
of dengue IgG antibodies (DENV-IgG Ab) among the population and to investigate potential associations with individual
and household characteristics.
Methods/Principal Findings: In November–December 2006 we conducted a cross-sectional serologic survey in Mayotte
among 1,154 inhabitants aged $2 years by using a multistage cluster random sampling method. The overall prevalence of
DENV-specific IgG antibodies (ELISA) was 22.73% (95% CI, 18.16–27.31). The age-specific seroprevalence increased with age
(x
2 for trend=11.86, P,0.0006), and was linked with previous known outbreaks in this region. In multivariate analysis, older
age, being born in the Comoros and living in a household with a low socioeconomic index were positively associated with
DENV IgG antibody positivity.
Conclusions: These findings document substantial prior exposure of the population of Mayotte to DENV and highlight the
risk of severe illness due to the possibility of sequential DENV infections. Further investigations characterizing current DENV
circulation patterns and associated serotypes are needed.
Citation: Sissoko D, Ezzedine K, Giry C, Moendandze ´ A, Lernout T, et al. (2010) Seroepidemiology of Dengue Virus in Mayotte, Indian Ocean, 2006. PLoS ONE 5(11):
e14141. doi:10.1371/journal.pone.0014141
Editor: Igor Mokrousov, St. Petersburg Pasteur Institute, Russian Federation
Received July 10, 2010; Accepted October 21, 2010; Published November 30, 2010
Copyright:  2010 Sissoko et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by the French Ministry of Health (Regional Bureau of Hospitalization, Local Bureau of Welfare and Social Affairs) and the French
Institute of Public Health Surveillance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: khaled.ezzedine@chu-bordeaux.fr
Introduction
Dengue is caused by one of four distinct dengue virus serotypes
(DENV-1–4) belonging to the family of Flaviviridae, genus Flavivrus.
Dengue infection is transmitted to humans through the bite of
infected mosquitoes of the genus Aedes, commonly Aedes aegypti and
Aedes albopictus [1]. The clinical picture of the illness may range from
asymptomatic, non-specific acute febrile illness (dengue fever) to a
fatal illness with hemorrhagic fever and circulatory shock known as
dengue haemorrhagic fever/dengue shock syndrome.
During the last decades, dengue has evolved rapidly as viruses
have spread worldwide expanding from Southeast Asia to the
Caribbean and Latin American. Moreover, it is expected to
disseminate further in receptive regions where competent vectors
are present [2]. This has led to a change in the status of numerous
countries, which have evolved from non-endemic (no serotype
present) to hyperendemic (continuous co-circulation of multiple
virus serotypes), as well as to an increase in the frequency of severe
disease forms [3]. Currently, dengue is a pandemic with worrying
public health implications throughout the tropics and subtropics.
Indeed, DENV is considered as the most important re-emerging
virus, directly threatening 2.5 billion people living in tropical/sub-
tropical areas and resulting in around 50–100 million cases of
dengue fever and 250 000 cases of dengue haemorrhagic fever,
together with a mortality rate of 25 000 yearly [4].
Serological evidence of dengue infection has been reported in
different countries or islands of the Eastern African costal region
[5,6,7,8,9]. DENV-2 was the first serotype formally identified in the
Southwest Indian Ocean Islands during the large outbreak that
affected the Seychelles in 1976–1977 and Reunion Island in 1977–
1978 with an estimated attack rate of respectively 60% and 35%
[5,10]. Subsequently, circulation of DENV-3 subtype III between
the East-Africa coastal region, Southeast Asia and Latin American
has been well characterised [11]. In addition, DENV-1 circulation
was reported during the outbreaks of dengue both in the Comoros
in 1993 (estimated attack rate of nearly 30%) [9] and Reunion in
2004 [12]. However, due to the lack of sustainable surveillance
systems, available data are sparse in most of the countries of this
region either during minor epidemics or during inter-epidemic
periods. This is particularly noteworthy in Mayotte, where the only
documentation of DENV circulation in the territory dates back to
1943 [13]. Since then, DENV circulation has been documented in
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population contact with Mayotte [5,9,10]. These islands share
similar conditions that favour the spread of DENV, presence of
dengue-competent vectors, comparable environmental and climatic
conditions, lack of effective mosquito control, rapid population
growth,uncontrolled urbanisationandinadequatewatersupplyand
waste management systems [14,15,16,17].
Recently, the dramatic appearance of persistent regional and
international outbreaks of Chikungunya virus (CHIKV) fever in
2005–2007 highlighted the vulnerability of the region to
arthropod-borne viruses and their capacity for rapid expansion
across the region and beyond [18,19,20]. These outbreaks have
drawn attention to the need for better understanding of the local
epidemiology of arboviruses in general and of DENV in particular.
In order to provide reference data on previous DENV circulation
in Mayotte, we have performed a serological survey with the goals
of estimating the seroprevalence of DENV IgG-antibodies among
individuals aged $2 years and to identify potential sociodemo-
graphic and environmental determinants of seropositivity.
Materials and Methods
Setting, design and population
The study was conducted in Mayotte, an insular French-
administered territory located in the Comoros archipelago between
the Eastern African coast and Madagascar (Figure 1). With regard
to the 2002 census, the estimated population in 2006 was 175 000
with a density of 468 inhabitants per square km. The population
originates primarily from Africa. Flow of immigrants from the
neighbouring Comoro Islands accounted for approximately 35% of
Mayotte’s population. The study setting has been described
previously [21]. The survey was carried out in conjunction with a
CHIKV-related population-based serologic survey in November
and December 2006,targeting the island population aged $2 years.
The survey used a multistage cluster sampling technique. In a first
step, 40 of the 400 enumeration areas- EAs (clusters) provided by the
2002 census blocks were sampled randomly with probability
proportionate to size, the size being the number of household in the
cluster. Secondly, a systematic walk from a random starting point was
performed to select 7 to 12 households (defined as groups of persons
sleeping or eating together) within each EA. Finally, in each selected
household, all adults (aged $15 years) and one individual aged 2–14
years (identified by using the next birthday selection method) were
invited to participate in the survey [22]. Consequently, individuals
belonging to the 2–14 year age group were under-represented in our
sample compared to the general population, since 43% of total
population of Mayotte is aged 0–14 years. To improve the level of
participation, household visits included weekends and holidays.
Moreover, when eligible members of the house were absent at the
time of the initial visit, surveyors made up to two additional visits.
Data collection
Participation in the survey was proposed on a voluntary basis. A
pre-coded and pre-tested structured questionnaire was adminis-
Figure 1. South-West Indian Ocean map with Mayotte.
doi:10.1371/journal.pone.0014141.g001
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language (Shimaori). Sociodemographic data were collected
relating to age, gender, educational level, country of origin and
length of residence in Mayotte (for foreigners). Data were also
collected on the housing environment, relating to the type of house
construction (Makeshift, adobe and stone, concrete) the number of
household residents, sanitary conditions and household facilities
such as electricity and drinking water source. Data on the housing
environment and on asset-ownership were collected with the
collaboration of a reference person for the household.
A six-point household asset index was calculated as a proxy for
socio-economic status for adults. This index was constructed on
the basis of availability of electricity (1 point), a flush toilet within
the household (1 point), piped water as source of drinking water
(1 point), possession of a television set (1 point), radio (1 point),
and a refrigerator (1 point). The number of items were summed
for each household and the household assigned to one of two
grades, namely low economic status (total score,median thresh-
old) and medium to high socioeconomic status (total score
$median threshold).
Laboratory methods. A venous blood sample was obtained
from each participant. Immediately after puncture, blood samples
were stored at 4–8uC and forwarded the same day to the
laboratory of the Mayotte Territorial Hospital, which was
responsible for all serologic testing. All serum samples were
tested for specific IgG DENV antibodies as a marker of past
infection using the Focus ELISA kit (Dengue Fever Virus IgG
Focus Diagnostics, Cypress CA, USA). A commercial assay for the
detection of IgG antibodies to dengue viruses was used (Focus
Diagnostics, Cypress, CA, US). The test is an indirect IgG assay
using a 96-well microtiter plate coated with equal proportions of
inactivated, purified DENV types 1–4 (Type 1: TH-Sman; Type 2:
TH-36; Type 3:H87; and Type 4: H241). Briefly, patient sera and
controls were diluted 1:101 in the kit diluent, and 0.1 ml was
added to wells. Negative and positive controls were included, as
was a kit-supplied calibrator/cutoff control. After incubation for
1 h at 37uC and washing three times with phosphate-buffered
saline (PBS), peroxidase-labeled rabbit anti-human IgG conjugate
was added to each well for 30 min. After the conjugation step and
the final wash series with PBS, tetramethylbenzidine (TMB) was
added, and the final reaction product was measured in a
spectrophotometer at a wavelength of 450 nm. An index value
was obtained for both control and patient samples by dividing the
absorbance value of the patients and controls by the absorbance
value of the calibrator (cutoff control). The optical density (OD) of
the specimen well was compared with the OD of the well
containing a calibration cut-off (CO) serum sample provided with
the kit. Those samples with OD: CO ratio $1 were recorded as
positive. The IgG ELISA assay used presented a sensitivity of
100% and a specificity of 88.3% [23].
Statistical analysis
Data were double entered and corrected for data entry errors
using EPIDATAH software version 3.0 (Epidata Association,
Odense, Denmark). All analyses were performed with STATAH
software version 10.0 (Stata Corporation, College Station, USA).
In the interest of representativity as regard to the reference
population, each participant was weighted by post stratification
according to age, gender, geographic location and household type
in order to account for unequal probabilities of selection resulting
from sampling cluster design of the study. For this purpose,
sampling weights were prepared and provided by the Regional
Bureau of the French National Institute for Statistics and
Economic Studies using the 2006 population estimation on the
basis of the 2002 census.
Crude and adjusted prevalence rates are presented by socio-
demographic and household variables. Overall and subgroup-
specific DENV seropositivity prevalence rates were estimated and
differences within sub-groups were compared using binomial
survey-adjusted Wald chi-square tests. P values,0.05 were
considered statistically significant.
In a next step, explanatory bivariate analyses using population-
adjusted weights to account for the survey design were performed
to assess potential associations between DENV seropositivity
(outcome of interest) and sociodemographic and housing variables.
Crude odds ratios (OR) and their 95% confidence interval (95%
CI) were estimated to explore the strength of the association
between DENV seropositivity and the variable of interest. This
analysis was only performed in the adult subgroup ($15 years).
Indeed, educational level and length of residence in Mayotte were
not considered applicable for risk factor analysis for individuals
aged 2–14 years.
Next, the association between variables identified in the
bivariate analysis and the outcome of interest were explored by
multivariable logistic regression analysis in order to control for
confounders. For this purpose, stepwise logistic regression models
including sociodemographic and household variables were
performed. All variables significantly associated with seropositiv-
ity at a probability threshold of #0.25 in the bivariate analyses
were entered into the initial multivariate models. For this
purpose, 36 individuals were excluded due to missing data for
at least one of the variables of interest, leaving a total of 852
observations. A backward stepwise procedure was used to select
variables retained in each of the final models [24]. Furthermore,
in order to retain a final model, a two-by-two interaction terms
were checked for variables that remained statistically significant
in the pre-final model. The strength of the association between
selected variables and DENV seropositivity was estimated by
adjusted odds ratios (AOR) with their 95% CI, all AOR
excluding 1.0 being considered as significant. In order to reflect
adequately association with outcome, confidence intervals for
AOR estimates were calculated on the basis of a log
transformation with the standard errors computed by the delta
method that took into account both clustering of individual
observations within households and non-independence of the
variables at household and region levels [25].
Ethical considerations
Publicity and information about the survey was provided
through the media, field visits to the local population, and contact
with local and national authorities. During visits, surveyors
introduced themselves to selected households and explained the
objectives and all procedures to the household members
concerned. A written consent form was first obtained from adults
or guardians of those individuals aged ,18 years prior to the
inclusion, unless they were illiterate, in which case signed consent
was sought from an appropriate family member chosen by the
participant. As the survey was combined with the determination
of CHIKV seroprevalence, it is important to note that we
solicited the agreement for testing several arboviruses including
DENV. This study was reviewed and approved by the ethics
committee of the Bordeaux University Hospital Centre, France,
in compliance with all French regulations on protection of human
subjects. A numbered code was attributed to all participants to
track blood samples. All data were handled confidentially and
anonymously.
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Characteristics of participants and prevalence of serum
DENV antibodies
Forty villages (clusters) were sampled and 508 inhabited
household visited. Of these, 418 households (82.3%) agreed to
participate in the study. The mean household size was 5.762.4
individuals [range: 1 to 13]. The selection procedure allowed the
recruitment of a total sample of 1156 individuals. Two participants
in the 2–14 years age group provided insufficient serum to undergo
serological evaluation and were thus excluded from the analysis.
Comparison of the sociodemographic characteristics of the
study sample to the reference demonstrated an adequate
agreement. However, the study sample was under-represented in
men compared to women (43?2% vs. 50?2% in 2006 population
projection) as well as over-represented in individuals belonging to
the 15–24-years age-group (25.5% vs. 20.2% in the 2006
population projection). These minor differences were accounted
for in the analyses of seroprevalence and risk factors by allocating a
weight to each participant.
The overall weighted seroprevalence of DENV antibodies in
Mayotte for individuals aged $2 years was 22.7% (95% CI, 18.2–
27.3) (Table 1). The age-specific weighted prevalence increased
with age (x2 for trend=11.86, P,0.0006). The peak age-specific
prevalence was observed in individuals of the 25–54 year age
group while those of the 2–14 age group presented the lowest
prevalence rate. When the analysis was restricted to individuals
born in Mayotte, the prevalence rate was highest in individuals
aged over 35 years (1.6% in the 2–14 age group, 4.6% in the 14–
24age group, 6.2% in the 25–34 age group, 15.7% in the 35–
44age-group, 22.2% in the 45–54 age group and 23.6% in
individuals over 55 years of age). Of the 302 children (age group
2–14), eight had serum DENV antibodies (weighted prevalence:
2.2%); Of these eight children, three were less than 10-years old
and born in Mayotte. No difference in the seroprevalence of
DENV antibodies was observed according to gender (Table 1).
The highest seroprevalence percentages were observed in the
Northern and the North-Eastern part of the island (Table 2).
Association between sociodemographic and household
variables and DENV seropositivity
In the bivariate analysis, DENV seropositivity was significantly
associated with a number of demographic and environmental
variables. For example, seropositivity was positively associated
with being born in another Comoro island (OR: 8.60; 95% CI:
5.56–13.27), whereas it was negatively associated with time at
school $6 years (OR=0.42, 95% CI: 0.26–0.66) and a longer
duration of residence in Mayotte. Individuals who had resided in
Mayotte for $15 years were protected from past infection as
compared to those who had resided for less than 5 years
(OR=0.18, 95% CI: 0.10–0.34). Moreover, living in a household
below the median asset index threshold or with a larger number of
household members (3–4 individuals) was significantly associated
with DENV seropositivity (Table 3).
In the multivariate logistic regression model, only two
demographic variables remained significantly associated with
Table 1. Weighted prevalence of serum IgG DENV antibodies according to demographic variables in participants aged $2 years,
Mayotte 2006.
Characteristic Tested individuals (N) Weighted prevalence (%) 95% Confidence interval
N (number of participants) 1154 22.7 18.2–27.3
Gender
Male 499 21.8 16.5–27.2
Female 655 23.6 18.7–28.6
Age group, years
02–14 302 2.2 0.7–3.7
15–24 294 19.1 12.9–25.6
25–34 193 34.0 24.9–43.1
35–44 169 35.8 23.0–48.7
45–54 107 38.8 23.7–53.8
$55 89 28.4 17.4–39.4
Birthplace*
Mayotte 446 10.6 6.8–14.5
Comoros 349 51.8 45.6–58.1
Other 60 17.3 1.7–32.9
Duration of residence, years {
,10 211 52.1 41.2–62.9
10–14 84 49.7 32.8–66.6
Over 15 108 36.9 25.9–47.9
Years of schooling*
0–6 679 31.3 24.8–37.7
.6 173 16.6 10.4–22.8
*Persons$15 years.
{For those adults ($15 years) born outside of Mayotte.
doi:10.1371/journal.pone.0014141.t001
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another Comoros island (Table 4). Concerning household-related
variables, living in a household of three to four members, as well as
living in makeshift house and a socioeconomic status index below
the median threshold were positively associated with DENV
seropositivity (Table 4).
Discussion
This is the first large-scale survey of the prevalence of dengue
infection and its potential determinants that has been conducted in
Mayotte. The overall weighted prevalence of IgG DENV
antibodies was 22.7%, ranging from 2.2% in children to almost
40% for individuals aged 45–54 years. This increasing age-related
prevalence of IgG DENV is consistent with previous studies
conducted in other endemic settings [26,27]. We observed that
previous DENV infection in adults was independently associated
with increasing age, low socio-economic status and household size.
In contrast, no difference in seroprevalence was found for gender.
Previous reports of potential gender differences in dengue
infections have been inconsistent, with some finding a higher
prevalence in men, others a higher prevalence in women, and
others no gender difference, in line with our findings [28,29,30].
This inconsistency may be related to variations in gender-specific
exposure according to local cultural practices.
The study identified a striking association of IgG DENV
prevalence with certain sociodemographic variables. Comorian
natives immigrating to Mayotte aged 15 years or over were around
ten-fold more affected than individuals of the same age born in
Mayotte. This finding may be, at least in part, related to the
outbreak of dengue that occurred in the neighbouring Comoros
islands in 1993 [9]. This epidemic hardly affected Mayotte, which
may explain the association observed.
Moreover, the age distribution of IgG DENV in the native
population of Mayotte reinforces this hypothesis. The peak of IgG
DENV prevalence in this group is observed in individuals aged 35
years or more, suggesting a link with the major dengue outbreak
that affected the South-Western Indian Ocean islands, in 1976–
1978, which was first reported in the Seychelles (1976–1977) [5]
and subsequently in Reunion (1977–1978) [6]. Although this
outbreak was well documented in these two countries, DENV
circulation in Mayotte was not reported at the time. However, it
can be speculated that the 1976–1978-DENV outbreak had in fact
probably spread to Mayotte as well, as did the recent persistent
regional outbreak of CHIKV infection, first reported in Reunion.
Another important finding is the evidence of past infection among
younger individuals, particularly those native to Mayotte and born
after the Comoros outbreak of 1993. This may suggest potentially
that low level transmission of DENV in Mayotte has continued
during the last decade. This is the first suggestion of inter-epidemic
transmission that has been described in Mayotte.
With respect to household variables, a higher risk for previous
DENV infection was found in households with a socio-economic
threshold below the median. In addition, there was a positive
association between household size and DENV seroprevalence,
which was restricted to households with three to four residents.
This particular finding may be related to the structure of the
questionnaire that assessed the number of inhabitants per
household rather than the density of inhabitants per room. The
latter variable may be more pertinent for evaluating potential
associations between DENV circulation and housing.
Our study has a number of limitations that should be
considered. Firstly, it was a cross sectional study relying on past
exposure, rather than a prospective incidence study. Secondly,
specific documentation of DENV serotypes that firmly establish
the circulation of different viral variants was not performed due to
logistic and financial constraints. On the other hand, this study
was conducted on a representative sample of the target population,
which is one of the strengths of the study. In particular, it was
weighted with respect to age, sex, and housing conditions relevant
to the local population, and also took into account local migratory
flux.
The advantage of using commercial ELISA to perform a high
throughput testing for DENV serology screening is well docu-
Table 2. Weighted prevalence of serum anti-DENV IgG antibodies according to household variables in individuals aged $2 years,
Mayotte, 2006.
Variable Tested individuals (N) Weighted prevalence, % 95% Confidence interval
House construction type
Makeshift 101 36.30 27.23–45.37
Adobe and stone 345 27.03 20.25–33.81
Concrete 708 18.89 13.76–24.02
Household size (number of inhabitants)
1–2 101 29.94 23.55–36.33
3–4 276 21.36 13.63–29.09
$5 777 18.40 13.36–23.45
Region of residence
Northeast 417 24.94 17.33–32.56
North 255 25.97 14.91–37.02
Midwest 303 17.66 9.59–25.73
South 179 19.91 14.45–23.37
Socioeconomic Asset index
Below the median 288 32.90 27.38–38.42
At or above the median 866 19.68 14.83–24.53
doi:10.1371/journal.pone.0014141.t002
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(DEN-1–4) and has a similar performance as the hemagglutination
test, considered to be the gold standard for indirect serologic
diagnosis of DENV infection [33]. Besides, ELISA testing for
DENV may also detect cross-reactive antibodies to other
flaviviruses, such as West Nile virus, whose circulation has been
reported in Madagascar [10]. However, it should be noted for the
limitation of this assumption that yellow fever has never been
reported and that immunization against the disease is neither
recommended by French Health authorities nor by the US CDC.
This is true for local inhabitants as well as for travellers to the
island. Moreover, no epidemic of West Nile virus has yet been
notified either in Mayotte or in Reunion Island.
This is the first cross-sectional study to demonstrate the
circulation of DENV in Mayotte using methods that discriminate
between different age groups and between different origins of
subjects. Hence DENV infection should be considered in the
differential diagnosis of influenza-like illnesses in routine clinical
practice in Mayotte. Moreover, routine laboratory surveillance
should be enhanced to improve the accuracy of detection of viral
circulation trends, including the identification of the specific
DENV serotypes involved. In parallel, community-specific habits,
customs or behaviours that increase the risk of mosquito-borne
infections should be identified to facilitate implementation of
prevention campaigns by health services and to educate the
general population.
A lot has been learnt from previous major outbreaks of
arboviral infections in the South-Western Indian Ocean region,
notably during the recent chikungunya virus epidemic. Contin-
uous efforts should be put into developing regional cooperation to
set up early warning systems and to ensure prompt responsiveness
to counter rapidly-spreading vector-borne viruses as due to the
presence in Mayotte of two competent vectors Aedes aegypti and Ae.
Albopictus [17].
Table 3. Unadjusted odds ratios for occurrence of serum anti-DENV IgG antibodies according to demographic and environmental
variables in individuals aged $15 years, Mayotte, 2006.
Crude odds ratio 95% Confidence interval P
Individual variables
Gender
Male 0.94 0.70–1.27 0.71
Female 1.00
Age, years
15–24 1.00
25–34 2.15 1.27–3.66 0.005
35–44 2.33 1.40–3.90 0.002
45–54 2.65 1.22–5.74 0.015
$55 1.66 0.85–3.24 0.136
Birthplace
Mayotte 1.00
Comoros 8.60 5.56–13.27 ,10
23
Other 1.76 0.55–5.53 0.33
Duration of residence, years
,5 1.00
5–14 1.08 0.55–2.11 0.24
Over 15 0.18 0.10–0.34 ,10
23
Years of schooling
0–6 1.00
$6 0.42 0.26–0.66 ,10
23
Household variables
Socioeconomic Asset index
Below the median 1.00
At or above the median 0.47 0.32–0.70 ,10
23
Household size (number of inhabitants)
1–2 1.00
3–4 3.34 1.62–6.88 0.002
$5 1.44 0.77–2.67 0.238
House construction type
Makeshift 1.00
Adobe and stone 0.57 0.29–1.11 0.10
Concrete 0.35 0.20–0.52 ,10
23
doi:10.1371/journal.pone.0014141.t003
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crossroads of Asia and Africa should be more thoroughly
monitored for dengue virus circulation, due to the increase in
intercontinental exchanges and legal and illegal immigration.
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